Drospirenone Synthesis via Oxidation Avoiding Hydrogenation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthetic routes for drospirenone production face challenges with low yields and high impurity levels due to undesired epimerizations and the need for hydrogenation steps, making industrial-scale manufacturing inefficient.
Innovation Solution
A process involving the reaction of compound 6 with a halogenated derivative, followed by oxidation using CrVI or MnIV-based oxidants, which avoids hydrogenation and reduces epimerization, enhancing yield and purity by directly converting intermediates to drospirenone without the need for hydrogenation or column chromatography.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If hydrogenation and oxidative lactonization are used in the final step, then the propynol group is reduced and drospirenone is formed, but process yield decreases and epimerizations occur
Solution Approach 1:
The invention extracts and eliminates the problematic hydrogenation step from the synthetic pathway. By using a modified route that avoids hydrogenation, the process prevents epimerization at C-13 and maintains high yield while achieving the desired drospirenone product with high purity.
Solution Approach 2:
The invention changes the reaction parameters and conditions in the final step. Instead of using traditional hydrogenation followed by oxidative lactonization, the process employs different reagents and conditions that directly form the lactone ring without causing epimerization, thereby maintaining both high yield and high purity.
2Productivity
If traditional synthetic routes are used, then drospirenone can be produced, but low yields and high impurity levels result due to epimerizations
Solution Approach 1:
The invention converts the potential harm of epimerization into benefit by designing a synthetic pathway that inherently prevents epimer formation. The modified route uses specific reagents and conditions that selectively form the desired stereoisomer, turning what would normally be a source of impurities into an advantage for achieving high purity product.
Solution Approach 2:
The invention performs preliminary actions in earlier steps of the synthesis to set up the molecular structure in a way that prevents epimerization in subsequent steps. By carefully controlling the configuration and protecting groups in intermediate steps, the process ensures that the final transformation proceeds with high stereoselectivity and yields the desired product with minimal impurities.
3Manufacturing precision
If multiple steps including hydrogenation and column chromatography are used, then drospirenone synthesis is complete, but the process becomes complex and inefficient for industrial scale
Solution Approach 1:
The invention merges multiple steps into a more streamlined process. By combining the final transformation steps and eliminating the need for column chromatography through improved selectivity, the process reduces the number of operational steps while maintaining high purity, making it more suitable for industrial-scale manufacturing.
Solution Approach 2:
The invention enables the reaction process to self-select for the desired product through inherent stereoselectivity and chemoselectivity. The reagents and conditions are designed to automatically favor the formation of the correct stereoisomer without requiring additional purification steps, allowing the process to essentially self-purify and reducing overall complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process increases product yield and purity, simplifies industrial-scale manufacturing by eliminating hydrogenation steps and column chromatography, and achieves high HPLC purity levels, making the production more attractive and efficient.
Implementation Method 1
oxidation of a compound of formula 8 with removal of protecting groups RI, RII or RIII to give drospirenone I
Data Source
AI summary
A process for the preparation of Drospirenone (I) according to the scheme (A) wherein the substituent R is defined in the description. The process improves the product yield and purity by reducing the formation of undesired side-products and is particularly convenient for industrial-scale manufacturing.